You are viewing a single comment's thread from:

RE: LeoThread 2025-11-11 16-48

in LeoFinancelast month

Part 2/5:

Using this genetic information, researchers design a custom-made mRNA vaccine tailored specifically to the patient’s unique cancer profile. This vaccine essentially acts as a biological alert system, instructing the immune system to recognize and target only the cancer cells harboring specific mutations or markers. The precision of this approach is crucial because cancer manifests differently from one individual to another, even within the same type of cancer.

The Manufacturing Timeline